微创医疗品牌怎么样 申请店铺

我要投票 微创医疗在精准医疗行业中的票数:357 更新时间:2025-04-27
微创医疗是哪个国家的品牌?「微创医疗」是上海微创医疗器械(集团)有限公司旗下著名品牌。该品牌发源于上海,由创始人常兆华在1998期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力微创医疗品牌出海!通过在本页面挂载微创医疗品牌的产品链接和联系方式,可以提高微创医疗产品曝光!跨境电商爆单神器,目前只要100元/年哦~

微创医疗怎么样

微创®起源于1998年成立的上海微创医疗器械(集团)有限公司,是一家中国出色的创新型医疗器械集团,总部位于中国上海张江科学城(上海市浦东新区张东路1601号) ,在中国上海、苏州、嘉兴、东莞,美国孟菲斯,法国巴黎近郊,意大利米兰近郊和多米尼加共和国等地均建有主要生产(研发)基地,形成了全球化的研发、生产、营销和服务网络。公司现有员工约5,000名,来自于30多个国家,其中过半数为中国员工。微创®专注于通过持续创新,为医生提供能挽救并重塑患者生命或改善其生活质量的真善美惠医疗解决方案。

微创®已上市产品约300个,覆盖心血管介入及结构性心脏病医疗、心脏节律管理及电生理医疗、骨科植入与修复、大动脉及外周血管介入、神经介入及脑科学、糖尿病及内分泌管理、泌尿及妇女健康、外科手术、医疗机器人与人工智能等十大业务集群。微创®的产品已进入全球逾8,000家医院,覆盖亚太、欧洲和美洲等主要地区。在全球范围内,平均每12秒就有一个微创®的产品被用于救治患者生命或改善其生活品质或用于帮助其催生新的生命。2014年推出的药物靶向洗脱支架系统更是令微创®在冠脉支架领域完成了从追随者和并跑者到全球带领者的跨越。

微创®人的创新动力源于一个属于患者和医生的品牌观,一切经营活动的理念和动机皆源自于患者,为了患者和用之于患者;一切创新的想法皆取之于医生,为了医生,并归之于医生。 “日月不以毫末而不照,雨露不以草草而不滋”,微创®人坚定地信仰人人都有生而平等的医疗权、健康权和追求活得更久的权利,并希冀与社会各界通力合作,为人人享有这种权利而积极创造各种各样的变革性医疗手段。微创®的远景(“以人为本,在以微创伤为代表的高科技医学领域建设一个属于患者的全球化医疗集团”)和使命(“持续创新,为医生提供能挽救并重塑患者生命或改善其生活质量的真善美惠医疗解决方案”)的核心就如同呼吸的空气、太阳的光芒和清晨的雨露一样,让代表全球高科技水平的医疗技术以公平、平等的方式,将健康和长寿带给世界上的每一个角落,每一个社区,每一个家庭和每一位患者。

秉承“致广致大致远致良知,尽精尽微尽心尽力”的管理理念,微创®在强调以人为本的同时,将对细节的追求和创新的坚持深深融入到企业基因之中。“患者和医生是并肩作战的战友,微创®是患者和医生的后勤保障,疾病是我们共同的敌人”,“为患者服务”和“为‘为患者服务的医生’服务”是微创®人共同的信仰。微创®人专注于与患者和医生结成命运共同体,缓解甚至消除各种慢性疾病对生命安全的严重威胁,并在把人类平均健康寿命提升至100岁、120岁甚至150岁的过程中,发挥越来越重要、甚至不可或缺的作用,为满足人类对“健康长寿”永无止境的美好追求做出重要贡献。


Minimally invasive ® originated from Shanghai minimally invasive medical devices (Group) Co., Ltd., established in 1998. It is an outstanding innovative medical device group in China. Its headquarter is located in Zhangjiang Science City, Shanghai, China (1601 Zhangdong Road, Pudong New Area, Shanghai). It is located in Shanghai, Suzhou, Jiaxing and Dongguan, China, Memphis, France, Paris, Milan, Italy and Dominican Republic And other places have established major production (R & D) bases, forming a global R & D, production, marketing and service network. The company has about 5000 employees, from more than 30 countries, of which more than half are Chinese employees. Minimally invasive ® focuses on providing doctors with true, good and beautiful medical solutions that can save and reshape patients' lives or improve their quality of life through continuous innovation. Minimally invasive ® has about 300 products on the market, covering ten business clusters, including cardiovascular intervention and structural heart disease medicine, cardiac rhythm management and electrophysiological medicine, orthopedic implantation and repair, large artery and peripheral vascular intervention, neural intervention and brain science, diabetes and endocrine management, urinary and women's health, surgical operation, medical robot and artificial intelligence. Minimally invasive products have entered more than 8000 hospitals around the world, covering major regions such as Asia Pacific, Europe and the Americas. Globally, on average, every 12 seconds, a minimally invasive ® product is used to treat patients' lives or improve their quality of life or to help them generate new lives. The drug-targeted eluting stent system launched in 2014 makes minimally invasive ® complete the leap from follower and parallel runner to global leader in the field of coronary stent. Minimally invasive ® people's innovation power comes from a brand concept belonging to patients and doctors. The concept and motivation of all business activities come from patients, for patients and for patients; all innovative ideas are taken from doctors, for doctors, and for doctors. "The sun and the moon don't shine, the rain and the dew don't nourish with grass and grass". Micro invasive people firmly believe that everyone has the right to health care, the right to health and the right to live longer, and hope to work together with all sectors of society to actively create a variety of transformative medical means for everyone to enjoy this right. Minimally invasive's vision ("people-oriented, building a global medical group for patients in the field of high-tech medicine represented by micro trauma") and mission ("continuous innovation, providing doctors with true, good and beautiful medical solutions that can save and reshape patients' lives or improve their quality of life") are like breathing air, sun light and morning rain In the same way, let the medical technology representing the global high-tech level bring health and longevity to every corner, every community, every family and every patient in a fair and equal way. Adhering to the management concept of "broad to the general, far to the conscience, meticulous to the utmost", micro invasive ® emphasizes people-oriented and deeply integrates the pursuit of details and innovation into the corporate gene. "Patients and doctors are comrades in arms, minimally invasive ® is the logistical support for patients and doctors, disease is our common enemy," serve patients "and" serve doctors for patients "are the common beliefs of minimally invasive ® people. Micro invasive people focus on forming a community of common destiny with patients and doctors to alleviate or even eliminate the serious threat of various chronic diseases to life safety, and play an increasingly important, even indispensable role in the process of raising the average healthy life of human beings to 100, 120 or even 150 years old, so as to make an important contribution to meet the endless pursuit of "healthy and long life" Offer.

本文链接: https://brand.waitui.com/c76f1c62f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中金公司:美图生活场景国内付费渗透率达5.2%

36氪获悉,中金公司研报透露,预计截至2月,美图公司生活场景下的国内付费渗透率已经达到5.2%。该场景下的产品包括美图秀秀、美颜相机、Wink等。据研报显示,美图生活场景产品国内付费渗透率突破5%,主要得益于生成式AI对传统功能的重新构建,如用AI去双下巴取代传统的手动推图,带来更好的用户体验和效果,促进订阅转化率提升。美图对生活场景应用订阅渗透率的长期目标为10%。

2小时前

惠誉博华:商业银行扩表节奏趋缓

36氪获悉,近日惠誉博华商业银行2024年度业绩点评。报告显示,2024年商业银行总资产同比增速回落至4.8%,结束此前连续三年的双位数扩张周期。从银行机构类型看呈现显著分化态势:城商行以8.9%的资产增速领跑,农商行以6.0%的增速紧随其后,国有大行与股份制银行分别录得3.9%和2.7%的增速。这种梯度差异映射出不同类别银行面临的经营环境——头部城商行凭借区域经济韧性维持相对活跃的资产扩张,而股份制银行负债端受制于存款成本刚性约束难以匹配国有大行资金优势,资产端受风险偏好与定价能力限制难以深度渗透区域下沉市场,导致信贷资源配置效率持续承压,近三年资产增速中枢较2019至2021年下降逾6个百分点,信贷市场正从增量竞争向存量优化转换。

2小时前

EHL酒店管理商学院将举办2025 年首届开放创新峰会

36氪获悉,EHL酒店管理商学院近日宣布,首届 EHL开放创新峰会将于5月20-21日在EHL瑞士洛桑校区举行。据悉本届峰会将围绕食品的未来、再生经济、奢品新义三个主题,打造切实可行的解决方案。EHL创新中心首席执行官Andrea Monti指出:“在这样一个充满活力与变革的时代,酒店及泛服务业对创新的需求比以往任何时候都更为迫切。”

2小时前

字节启动Top Seed大模型顶尖人才计划2026届校招

36氪获悉,4月27日,字节跳动Seed正式启动2026届Top Seed大模型顶尖人才校招计划。据了解,此前3月Top Seed开放了研究型实习生招聘,今日起正式启动2026届校招,计划招募约30位顶尖应届博士。本届Top Seed研究课题包括大语言模型、机器学习算法和系统、多模态生成、多模态理解、语音等方向,基本覆盖大模型研究各个领域。值得一提的是,本届Top Seed强调不限专业背景,更关注研究潜力,希望寻找具有极强技术信仰与热情、具备出色研究能力、富有好奇心和驱动力的年轻研究者。

2小时前

硅基智能1000万美元购入DUIX.com域名

近日,AI数字人科技公司硅基智能以1000万美元收购稀缺四字母.com域名DUIX.com,并同步上线同名数字人实时交互平台。据介绍,DUIX,全称Dialogue User Interface System,定位为新一代数字人智能交互基础设施,提供API接入、SDK开发包、免费实时体验入口及多场景应用案例。该平台支持数字人多模态交互,覆盖情感陪伴、客服、教育、医疗、游戏等应用场景,帮助开发者快速搭建实时交互式体验。

2小时前

本页详细列出关于微创医疗的品牌信息,含品牌所属公司介绍,微创医疗所处行业的品牌地位及优势。
咨询